Eccles D M, Lunt P W, Wallis Y, Griffiths M, Sandhu B, McKay S, Morton D, Shea-Simonds J, Macdonald F
Wessex Clinical Genetics Service, Princess Ann Hospital, Southampton.
Arch Dis Child. 1997 Nov;77(5):431-5. doi: 10.1136/adc.77.5.431.
Familial adenomatous polyposis (FAP) is a dominantly inherited predisposition to the development of many hundreds to thousands of adenomatous polyps of the colon. The mean age of onset is around 15 years, symptoms may arise in the third decade, and the median age for the development of colonic cancer is 35-40 years. Prophylactic colectomy reduces the risk of death from colorectal cancer to such an extent that late sequelae such as upper gastrointestinal tumours have become the main cause of mortality in appropriately managed patients. The age at which colonic surveillance begins reflects the natural history of the disease. Onset of polyp formation and cancer in childhood is very unusual, but has recently been associated with a specific mutation at codon 1309 in exon 15 where a more severe phenotype is sometimes observed. The case histories of two families are reported in which there is childhood onset of polyps in the youngest generation and in one case a carcinoma, in whom mutations have been identified in exon 11 of the APC gene. Several other affected relatives were diagnosed at ages ranging from 5-48 years, some already with a cancer at the time of first screening. Since the aim of screening for colonic polyps is prevention of colonic cancer, family members at risk should be offered genetic assessment and direct mutation testing where this is possible, usually in the early teens. In the absence of a genetic test (the situation in about one third of families) or in a known gene carrier, annual colonoscopy examination is advised from the same age. Clinicians should take note of the family history and be prepared to consider much earlier intervention if symptoms occur in a child with a family history of FAP. Where childhood onset of polyps has occurred, other children at risk in the family must be offered earlier genetic testing and endoscopic surveillance.
家族性腺瘤性息肉病(FAP)是一种显性遗传易患疾病,易发展成数百至数千个结肠腺瘤性息肉。平均发病年龄约为15岁,症状可能在第三个十年出现,结肠癌发生的中位年龄为35 - 40岁。预防性结肠切除术将结直肠癌死亡风险降低到一定程度,以至于诸如上消化道肿瘤等晚期后遗症已成为管理得当的患者的主要死亡原因。结肠监测开始的年龄反映了该疾病的自然史。儿童期息肉形成和癌症的发生非常罕见,但最近已与外显子15中第1309密码子的特定突变相关,有时会观察到更严重的表型。报告了两个家族的病例史,其中最年轻一代在儿童期出现息肉,在一个病例中出现了癌,在这些病例中已在APC基因的外显子11中鉴定出突变。其他几名受影响的亲属在5 - 48岁之间被诊断出,一些人在首次筛查时就已经患有癌症。由于筛查结肠息肉的目的是预防结肠癌,对于有风险的家庭成员,应在可能的情况下,通常在青少年早期提供基因评估和直接突变检测。在没有基因检测的情况下(约三分之一的家族是这种情况)或对于已知的基因携带者,建议从相同年龄开始每年进行结肠镜检查。临床医生应注意家族史,如果有FAP家族史的儿童出现症状,应准备考虑更早的干预。如果儿童期出现息肉,必须为家族中其他有风险的儿童提供更早的基因检测和内镜监测。